Pelvic inflammatory disease

Sexually Transmitted Diseases

Volumn 18, Issue 1, 1991, Pages 46-64

  Wasserheit, Judith N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; CEFOXITIN; CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; PROCAINE PENICILLIN;

BACTEROIDES; CHLAMYDIA TRACHOMATIS; COST; FEMALE; GARDNERELLA VAGINALIS; HUMAN; MYCOPLASMA; NEISSERIA GONORRHOEAE; PELVIC INFLAMMATORY DISEASE; REVIEW; RISK FACTOR; VAGINITIS;

FEMALE; HUMAN; PELVIC INFLAMMATORY DISEASE; RESEARCH; UNITED STATES;

EID: 0025911630     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/00007435-199101000-00011     Document Type: Article

References (200)

1. Aral SO, Mosher WD, Cates W. Self-reported pelvic inflammatory disease in US women of reproductive age: A common occurrence. Am J Public Health 1985; 75:1216-1218.
2. Aral SO, Holmes KK. Epidemiology of sexual behavior and sexually transmitted diseases. In: Holmes KK, Mardh P-A, Sparling PF, et al. (eds.) Sexually Transmitted Diseases. Second edition, McGraw-Hill Information Services Co., New York, NY: 1989:19-36.
3. Aral SO, Mosher WD, Cates W. Self-reported pelvic inflammatory disease among women of reproductive age: United States 1988 (forthcoming).
4. Bell TA, Holmes KK. Age-specific risks of syphils, gonorrhea, and hospitalized pelvic inflammatory disease in sexually experienced U. S. women. Sex Transm Dis 1984; 11:291-295.
5. Beral V. An epidemiological study of recent trends in ectopic pregnancy. Br J Obstet Gynaecol 1975; 82:775-782.
6. Cates W, Wasserheit JN. Gonorrhea, chlamydia and pelvic inflammatory disease: A review of the recent literature. Curr Opinion Infect Dis 1990; 3:10-19.
7. Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease and infertility: An epidemiologic update. Epidemiol Rev 1990: (in press).
8. Centers for Disease Control. Ectopic pregnancy-United States, 1987. MMWR 1990; 39:401-404.
9. Centers for Disease Control. Ectopic pregnancy surveillance. United States 1970-85. In: CDC Surveillance Summaries, December 1988. MMWR 1988; 37(No. SS-5):9-18.
10. Chow WH, Daling JR, Weiss NS, Moore DE, Soderstrom R. Vaginal douching as a potential risk factor for tubal ectopic pregnancy. Am J Obstet Gynecol 1985; 153:727-729.
11. Chow JM, Yonekura L, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy: A matched-pair, case-control study. JAMA 1990; 263:3164-3167.
12. Cramer DW, Schiff I, Schoenbaum SC, et al. Tubal infertility and the intrauterine device. N Engl J Med 1985; 312:941-947.
13. Cramer DW, Goldman MB, Schiff I, et al. The relationship of tubal infertility to barrier method and oral contraceptive use. JAMA 1987;257:2446-2450.
14. Cromer BA, Heald FP. Pelvic inflammatory disease associated with Neisseria gonorrhoeae and Chlamydia trachomatis: Clinical correlates. Sex Transm Dis 1987; 14:125-129.
15. Daling JR, Weiss NS, Metch DJ, et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985;312:937-941.
16. Forrest KA, Washington AE, Daling JR, Sweet RL. Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc 1989;81:159-165.
17. Gelphman KA, Gale JL, Commons M, Thapa PB, Handsfield HH. Pelvic inflammatory disease: Diagnosis and treatment patterns as reported by private providers. Presented to the International Society for STD Research, Atlanta, GA. August 2-5, 1987.
18. Grimes DA. Intrauterine devices and pelvic inflammatory disease: Recent developments. Contraception 1987; 36:97-109.
19. Hoegsberg B, Abulatia O, Sedlis A, et al. Sexually transmitted diseases and human immunodeficiency virus among women with pelvic inflammatory disease. Am J Obstet Gynecol, in press.
20. Katz BP, Danos CS, Quinn TS, Caine V, Jones RB. Efficiency and cost-eflectiveness of field follow up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis 1988; 15:11-16.
21. Kelaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982; 248:184-187.
22. Kessel E. Pelvic inflammatory disease with intrauterine device use: A reassessment. Fertil Steril 1989; 51:1-11.
23. Lee NC, Rubin GL, Boruck R. The intrauterine device and pelvic inflammatory disease revisited: New results from the Women’s Health Study. Obstet Gynecol 1988; 72:1-6.
24. Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1-6.
25. Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol 1990; 162:639-644.
26. McGregor JA, Spencer NE, French JL, et al. Psychosocial behavioral risk factors for acute salpingitis. In: Abstract of the 6th International meeting of the International Society for STD Research, Brighton, U.K., July 31-August 2, 1985.
27. Newton W, Keith LG. Role of sexual behavior in the development of pelvic inflammatory disease. J Reprod Med 1985; 30:82-88.
28. Shafer MA, Sweet RL. Pelvic inflammatory disease in adolescent females. Epidemiology, pathogenesis, diagnosis, treatment, and sequelae. Pediatr Clin N Am 1989; 36:513-532.
29. Sinei SKA, Schulz KF, Lamptey PR, et al. Prevention IUD-related pelvic infection: The efficacy of prophylactic doxycycline at insertion. Br J Obslet Gynecol 1990; 97:412-419.
30. Sweet RL, Blankfort-Doyle M, Robbie MO, Schachter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986; 255:2062-2064.
31. Washington A, Arno PS, Brooks MA. The economic cost of pelvic inflammatory disease. JAMA 1986; 255:1735-1738.
32. Washington AE, Cates W, Zaidi AA. Hospitalizations for pelvic inflammatory disease: Epidemiology and trends in the United States 1975-1981. JAMA 1984; 251:2529-2533.
33. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease: A word of caution about protection. JAMA 1985; 253:2246-2250.
34. Washington AE, Padian NS, Hearst N, Schachter J. Risk of chlamydial PID and oral contraceptives. JAMA. 1990; (in press).
35. Westrom L, Mardh PA. Acute pelvic inflammatory disease (PID). In: Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ, Cates W Jr, Lemon SM, Stamm WE, (eds.) Sexually Transmitted Diseases, 2nd Edition. New York, NY: McGraw-Hill; 1989:593-613.
36. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990; 263:1936-1941.
37. Wolner-Hanssen PW, Kiviat NB, Holmes KK. Atypical pelvic inflammatory disease: Subacute, chronic or subclinical upper genital tract infection in women. In: Holmes KK, Mardh PA, Sparling PF, et al. (ed.) Sexually Transmitted Diseases, 2nd edition. New York: McGraw-Hill Company; 1990:615-620.
38. Apicella MA, Westerink MAJ, Morse SA, et al. Bactericidal antibody response of normal human serum to the lipooligosaecharide of Neisseria gonorrhoeae. J Infect Dis 1986; 153:520-526.
39. Arya OP, Mallison H, Goddard AD. Epidemiological and clinical correlates of chylamydial infection of the cervix. Br J Vener Dis 1981; 57:118-124.
40. Barron AL, White HJ, Rank RG, et al. A new animal model for the study of Chlamydia trachomatis genital infections: Infection of mice with the agent of mouse pneumonitis. J Infect Dis 1981; 143:63-66.
41. Blake MS, Gostschlich EC. Gonococcal membrane proteins: Speculation on their role in pathogenesis. Prog Allergy 1983: 33:298-313.
42. Bose SK, Goswami PC. Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment to HeLA cells. Infect immun 1986; 53:646-650.
43. Bowie WR, Wexander ER, Holmes KK, et al. Etiologies of postgono-coccal urethritis in homosexual and heterosexual men: Role of Chlamydia trachomatis and Ureaplasma urealyticum. Sex Transm Dis 1978; 5:151-154.
44. Brunham RC, Peeling R, MacLean I, et al. Post abortal Chlamydia trachomatis salpingitis: Correlating risk with antigenic-specific serological responses and with neutralization. J Infect Dis 1987; 155:749-755.
45. Chow AW, Malkasian KL, Marshall JR, et al. The bacteriology of acute pelvic inflammatory disease: Value of cul-de-sac cultures and relative importance of gonococci and other aerobic and anaerobic bacteria. Am J Obstet Gynecol 1975; 122:876-879.
46. Densen P. Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae. Clin Microbiol Rev 1989; 2:S11-S17.
47. Densen P, Gulati S, Rice PA. Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. J Clin Invest 1987;80:78-87.
48. Densen P, MacKeen LA, Clark RA. Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro. Infect Immun 1982; 38:563-572.
49. Eschenbach D, Harnisch JP, Holmes KK. Pathogenesis of acute pelvic inflammatory diseases: Role of contraception and other risk factors. Am J Obstet Gynecol 1977; 128:838-850.
50. Eschenbach D, Bachanan TM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975; 293:166-171.
51. Fitzgerald TJ, Morse SA. Alteration of growth, infectivity and viability of Neisseria gonorrhoeae by gonadal steroids. Can J Microbiol 1976; 22:286-294.
52. Fraser JJ, Rettig PJ, Kaplan DW. Prevalence of cervical Chlamydia trachomatis and Neisseria gonorrhoeae in female adolescents. Pediatrics 1983; 71:333-336.
53. Fredicsson B, Hagstom B, Evaldson G, et al. Gardnerella, associated vaginitis and anaerobic bacteria. Gynecol Obstet Invest 1984; 17:236-241.
54. Goldacre MJ, Loudon N, Watt B, et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J 1978; 1:748-750.
55. Grayston JT, Wang SP, Yeh L-J, et al. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7:717-725.
56. Gregg CR, Melly MA, Hellerqvist GC, et al. Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis 1981; 143:432-439.
57. Hallberg T, Wolner-Hanssen P, Mardh P-A. Pelvic inflammatory disease in patients, infected with Chlamydia trachomatis: In vitro cell-ediated immune response to chlamydial antigens. Genitourin Med 1985; 61:247-251.
58. Hallen A, Pahlson C, Forsum U. Bacterial vaginosis in women attending STD clinic: Diagnostic criteria and prevalence of Mobilutncos spp. Genitourin Med 1987; 63:386-389.
59. Hanna L, Schmidt L, Sharp M, et al. Human cell-mediated immune response to chlamydial antigens. Infect Immun 1979; 23:412-417.
60. Harrison HR. Cervical Chlamydia trachomatis infection in university women: Relationship to history of contraception, ectopy, and cervicitis. Am J Obstet Gynecol 1985; 153:244-251.
61. Holmes KK, Eschenbach DA, Knapp JS. Salpingitis: Overview of etiology and epidemiology. Am J Obstet Gynecol 1980; 138:893-900.
62. Inman RD, Johnston MEA, Chiu B, et al. Immunochemical analysis of immune response to Chlamydia trachomatis in Reiter’s syndrome and nonspecific urethritis. Clin Exp Immunol 1987; 69:246-254.
63. Jordan JA, Singer A. Effect of oral contraceptive steroids upon epithelium and mucus. In: Jordan JA, Singer A (eds.): The Cervix. Philadelphia: WB Saunders Co., 1976:192-207.
64. Kasper DL, Rice PA, McCormack WM. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J Infect Dis 1977; 135:243-251.
65. Kearns DH, et al. Paradox of the immune response to uncomplicated gonococcal urethritis. N Engl J Med 1973: 289:1170-1178.
66. Kinghorn GR, Waugh MA. Oral contraceptive use and prevalence of infection with Chlamydia trachomatis in women. Br J Vener Dis 1981; 57:187-190.
67. Kraus SJ, Perkins GH, Geller RC. Lymphocyte transformation in repeated gonococcal urethritis. Infect Immun 1970; 2:655-658.
68. 2 production by human monocyte-derived macrophages infected with C. trachomatis. In: Bowie WR, Caldwell HD, Jones RP, et al. (eds.). Proceedings of the 7th International Symposium on Human Chlamydial Infections, Cambridge University Press, Cambridge 1990:209-212.
69. Mardh P-A. An overview of infectious agents in salpingitis: Their biology and recent advances in methods of detection. Am J Obstet Gynecol 1989; 138:933-951.
70. McGee ZA, Johnson AP, Taylor-Robinson D. Pathogenic mechanisms of Neisseria gonorrhoeae: Observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J Infect Dis 1981; 143:413-422.
71. Melly MA, Gregg CR, McGee ZA. Studies of toxicity of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis 1981; 143:423-431.
72. Melly MA, McGee ZA, Rosenthal RS. Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis 1984; 149:378-386.
73. Moller BR, Westrom L, Ahrons S, et al. Chlamydia trachomatis infection of the fallopian tubes: Histological findings in two patients. Br J Vener Dis 1979; 55:422-428.
74. Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis: Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 1989; 169:663-675.
75. Murray ES, Radcliffe FT. Immunologic studies in guinea pigs with guinea pig inclusion conjunctivitis (GP-IC) Bedsonia. Am J Opthalmol 1967;63:1263-1269.
76. Noonan AS, Adams JB. Gonorrhoea screening in an urban hospital family planning program. Am J Public Health 1974; 64:700-704.
77. Paavonen J, Geisala K, Heinonen PK, et al. Microbiological and histological findings in acute pelvic inflammatory disease. Br J Obstet Gynecol 1987; 94:454-460.
78. Patton DL, Halbert SA, Kuo CC, et al. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pigtailed monkeys. Fertil Steril 1983;40:829-840.
79. Patton DL, Kuo C-C. Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J Reprod Fert 1989; 85:647-656.
80. Patton DL, Kuo C-C, Wang SP, et al. Distal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pigtailed macaques. J Infect Dis 1987; 155:1292-1299.
81. Patton DL, Landers DV, Schachter J. Experimental Chlamydia trachomatis salpingitis in mice: Initial studies on the characterization of the leukocyte response to chlamydial infection. J Infect Dis 1989; 159:1105-1110.
82. Patton DL, Wang SP, Sternfield MD, et al. Chlamydial infection of subcutaneous fimbrial transplants in cynomologus and rhesus monkeys. J Infect Dis 1987; 155:229-235.
83. Patton DL, Wolner-Hanssen P, Cosgrove SJ, et al. Histopathology of the female reproductory tract of the pig-tailed macque after tubal challenge following repeated cervical infection with Chlamydia trachomatis. Abstract 31, International Society for STD Research, Copenhagen, Denmark, 1989.
84. Piot P, Van Dyck E, Godts P, et al. The vaginal microbial flora in nonspecific vaginitis. Eur J Clin Microbiol 1982; 1:301-306.
85. Plaut AG. Neisseria gonorrhoeae and Neisseria meningitis: Extracellular enzyme cleaves human immunoglobin A. Science 1975; 190:1103-1105.
86. Rabe LK, Winterscheid KK, Hillier SL. Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection. J Clin Microbiol 1988; 26:156-1160.
87. Rank RG, Barron AL. Specific effect of estradiol on the genital mucosal antibody response in chlamydial ocular and genital infections. Infect Immun 1987; 55:2317-2319.
88. Rank RG, White HJ, Hough AJ, et al. Effect of estradiol on chlamydial genital infection of female guinea pig. Infect Immun 1982; 38:699-705.
89. Rank RG, Barron AL. Prolonged genital infection by GPIC agent associated with immunosuppression following treatment with estradiol. In: Mardh P-A, Holmes KK, Oreil JD, et al. (eds.): Chlamydia Infections. Amsterdam: Elsevier Biomedical Press, 1982:391-394.
90. Rees E, Tait A, Hobson D, et al. Chlamydia in relation to cervical infection and pelvic inflammatory disease. In: Hobson D, Holmes KK (eds.) Nongonococcal Urethritis and Related Infections. Washington DC: American Society of Microbiology, 1977:67-76.
91. Rice PA, McCormack WM, Kasper DL. Natural serum bactericidal activity against Neisseria gonorrhoeae from disseminated, locally invasive, and uncomplicated disease. J Immunol 1980; 124:2105-2109.
92. Ripa KT, Svensson L, Treharne JD, et al. Chlamydia trachomatis infection in patients with laparoscopically verified acute salpingitis: Results of isolation and antibody determinations. Am J Obstet Gynecol 1980; 138:960-964.
93. Ryden G, Fahraeus L, Molin L, et al. Do contraceptives influence the incidence of acute pelvic inflammatory disease in women with gonorrhea? Contraception 1979; 20:149-157.
94. Salit IE. The differential susceptibility of gonococcal opacity variants to sex hormones. Can J Microbiol 1982; 28:301-306.
95. Schachter J, Stoner E, Moncada J. Screening for chlamydia infections in women attending family planning clinics: Evaluation of presumptive indicators of therapy. West J Med 1983; 138:375-379.
96. Schoolnik GK, Buchanan TM, Holmes KK. Gonococci causing disseminated infection are resistant to the bactericidal action of normal human sera. J Clin Invest 1976; 58:1163-1173.
97. Senanayake P, Kramer DG. Contraception and the etiology of PID: New perspectives. Am J Obstet Gynecol 1980; 138:852.
98. Shafer M-A, Beck A, Blain B, et al. Chlamydia trachomatis: Important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr 1984; 104:141-146.
99. Sweet RI, Draper DL, Hadley WK. Etiology of acute salpingitis: Influence of episode number and duration of symptoms. Obstet Gynecol 1981: 58:62-68.
100. Swinker ML, Young SA, Cleavenger RL, et al. Prevalence of Chlamydia trachomatis cervical infection in a college gynecology clinic: Relationship to other infections and clinical features. Sex Transm Dis 1988; 15:133.
101. Svensson L, Westrom L, Mardh P-A. Chlamydia trachomatis in women attending a gynecological outpatient clinic with lower genital tract infection. Br J Vener Dis 1981; 57:259-262.
102. Targum SD, Wright NH. Association of the intrauterine device and pelvic inflammatory disease: A retrospective pilot study. Am J Epidemiol 1974; 100:262-271.
103. Taylor HR, Johnson SL, Schachter J, et al. Pathogenesis of trachoma: The stimulus for inflammation. J Immunol 1987; 138:3023-3027.
104. Taylor-Robinson D, Tuffrey M, Falder P. Some aspects of animal models for Chlamydia trachomatis genital infection. In: Mardh P-A, Holmes KK, Oriel JD, et al. (eds.): Chlamydial Infections. Amsterdam: Elsevier Biomedical Press, 1982:375-378.
105. Tramont EC. Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J Clin Invest 1977; 59:117-124.
106. Tuffrey M, Falder P, Taylor-Robinson D. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 1982; 63:539-546.
107. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital infection with Chlamydia trachomatis. FEBS Lett 1981; 12:111-115.
108. Vaughan-Jackson JD, Darougar S, Treharne JD, et al. Urethritis due to Chlamydia trachomatis. Br J Vener Dis 1977; 53:180-183.
109. Watkins NG, Hadlow WJ, Moos AB, et al. Ocular delayed hypersensitivity: A pathogenetic mechanism of chlamydial conjunctivitis in guinea pigs. Proc Natl Acad Sci USA 1986; 83:7480-7484.
110. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138:880-892.
111. Westrom L, Mardh P-A. Chlamydial salpingitis. Br Med Bull 1983; 39:145-150.
112. Wolner-Hanssen P, Svensson L, Mardh P-H, Westrom L. Laparascopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet Gynecol 1985; 66:233-238.
113. Wyrick PB, Sixbey JW, Davis CH, et al. Growth of Chlamydia trachomatis in human cervical epithelial cell monolayers. In: Mardh P-A, Holmes KK, Oriel JD, et al. (eds.). Chlamydial infections. Amsterdam: Elsevier Biomedical Press, 1982:275-278.
114. Aaran RK, Lehtinen M, Kallionoemi OP, et al. Serum Ca 125 and TAT 1 levels in inpatients and outpatients with pelvic inflammatory disease. Abstract, Int’l Soc for STD Res, Sept. 1989.
115. Aral SO, Mosher WD, Cates W. Self-reported pelvic inflammatory disease in the US: A common occurrence. Am J Public Health 1985; 75:1216-1218.
116. Bongard F, Landers DV, Lewis F. Differential diagnosis of appendictis and pelvic inflammatory disease: A prospective analysis. Am J Surg 1985; 150:90-96.
117. Chaparro MV, Ghosh A, Nashed A, Poliak A. Laparoscopy for the confirmation and prognostic evaluation of pelvic inflammatory disease. Int J Gyn Obstet 1978; 15:307-309.
118. Eschenbach DA. Epidemiology and diagnosis of acute pelvic inflammatory disease. Obstet Gynecol 1980; 55:142S-52S.
119. Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: A multivariate analysis. Am J Obstet Gynecol 1986; 155:954-60.
120. Hagar WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61:113-114.
121. Hemila M, Henriksson L, Ylikorkala O. Serum CRP in the diagnosis and treatment of pelvic inflammatory disease. Arch Gynecol Obstet 1987; 241:177-182.
122. Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969; 105:1088-1098.
123. Jones OG, Zaidi AA, St. John AK. Frequency and distribution of salpingitis and pelvic inflammatory disease in short-stay hospitals in the United States. Am J Obstet Gynecol 1980; 138:905-908.
124. Kiviat NB, Wolner-Hassen P, Eschenbach DA, et al. Endometrial histopathology in patients with culture-proven upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990; 14:167-175.
125. Lehtinen M, Laine S, Heinonen PK, et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol 1986; 154:158-159.
126. Paavonen J, Aine R, Teisala K, et al. Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1985; 151:645-650.
127. Paavonen J, Cacciatore B, Leminen A, Ingman-Friberg S, Yiostalo P. Outpatient diagnosis of pelvic inflammatory disease. In: Bowies et al. (eds.) Chlamydial Infections: Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Cambridge: Cambridge University Press, 1990:307-321.
128. Rothenberg RB, Simon R, Chipperhield K, Catterall RD. Efficacy of selected diagnostic tests for sexually transmitted diseases. JAMA 1976; 235:49-51.
129. Sellors JW, Mahoney JB, Goldsmith C, et al. The diagnosis of pelvic inflammatory disease (PID): The accuracy of clinical and laparoscopic findings. Abstract, Int’l Soc STD Res. Sept 1989.
130. St. John RK, Jones OG, Blount JH, Zaidi AA. Pelvic inflammatory disease in the United States: Epidemiology and trends among hospitalized women. Sex Transm Dis 1981: 8:62-66.
131. Svennsson L. Westrom L. Ripa KT, et al. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serological findings. Am J Obstet Gyn 1980; 138:1017-1021.
132. Sweet RL, Mills J, Hadly KW, et al. Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol 1979; 134:68.
133. Tavelli BG, Judson FN. Comparison of the clinical and epidemiologic characteristics of gonococcal and nongonoccal pelvic inflammatory disease seen in a clinic for sexually transmitted diseases, 1978-1979. Sex Transm Dis 1986; 13:119-22.
134. Washington AE, Cates W, Zaidi AA. Hospitalizations for pelvic inflammatory disease: Epidemiology and trends in the United States, 1975 to 1981. JAMA 1984; 251:2529-2533.
135. Westrom I. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121:707.
136. Westrom L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138:880-892.
137. Westrom L. Clinical manifestation and diagnosis of pelvic inflammatory disease. J Reprod Med 1983; 28(Suppl.):703-708.
138. Wolner-Hanssen P, Mardh hPA, Svensson L, Westrom L. Laparoscopy in women with chlamydial infection and pelvic pain: A comparison of patients with and without salpingitis. Obstet Gynecol 1983;61:299-303.
139. Wolner-Hanssen P, Svensson L, Mardh PA, Westrom L. Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet Gynecol 1985; 66:223-238.
140. Apuzzio JJ, Stankiewiecz R, Ganesh V, Jain, Kaminiski Z, Louria D. Comparison of parenteral ciprofloxacin with clindamycingentamicin in the treatment of pelvic infection. Am J Med 1989; 87(Supppl. 5A): 148s-151s.
141. Brihmer C, Brundin J. Second look laparoscopy after treatment of acute salpingitis with doxycycline/bensylpencillin procaine or trimethorpim-sulfamethoxazole. Scand J Infect Dis 1988; 53(Suppl.):65-69.
142. Bruhat MA, Le Bouedec G, Pouly JL, Mage G, Canis M. Treatment of acute salpingitis with sulbactam/ampicillin. Int J Gynecol Obstet 1989; (Suppl. 2):41-6.
143. Brumsted JR, Clifford PM, Nakajima ST, Gibson M. Reproductive outcome after medical management of complicated pelvic inflammatory disease. Fertil Steril 1988; 50:667-669.
144. Brunham RC, Binns B, Guijon F, et al. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 1988; 158:510-517.
145. Brunham RC. Therapy for acute pelvic inflammatory disease: A critique of recent treatment trials. Am J Obstet Gynecol 1984; 148:235-240.
146. Campbell WF, Dodson MG. Clindamycin therapy for Chlamydia trachomatis in women. Am J Obstet Gynecol 1990; 162:343-347.
147. Centers for Disease Control. 1985 STD treatment guidelines. MMWR 1985; 34(Suppl. 4S):19-21.
148. Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. MMWR 189; 38(No. S-8):31-33.
149. Crombleholme WR, Schachter J, Grossman M, Landers DV, Sweet RL. Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol 1990; 75:752-756.
150. Crombleholme WR, Schachter J, Ohm-Smith M, Luft J, Whidden R, Sweet RL. Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. Am J Med 1989; 87(Suppl. 5): 142s-147s.
151. Crombleholme W, Landers D, Ohm-Smith M, Robbie MO, Hadley WK, DeKay V, Dahrouge D, Sweet RL. Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. Drugs 1986; 31 (Suppl. 2): 11-13.
152. Dodson MG, Faro S, Gentry LO. Treatment of acute pelvic infiammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin. Obstet Gynecol 1986; 67:657-662.
153. Faro S, Martens MG, Philips LE, Lapread E, Riddle GD, Turner RM. Ceftizoxime versus cefotaxime in the treatment of hospitalized patients with pelvic inflammatory disease. Curr Ther Res 1.988; 43:349-354.
154. Gunning J. A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease. Drugs 1986; 31 (Suppl. 2): 14-17.
155. Heinonen PK, Teisala L, Aine R, Miettinen A. Brief report: Intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease: A comparison with doxycycline and metronidazole. Am J Med 1989; 87(Suppl. 5A): 152s-156s.
156. Heinonen PK, Teisala K, Miettinen A, Aine R, Punnonen R, Gronroos RP. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. Scand J Infect Dis Suppl 1989; 60:66-73.
157. Heinonen PK, Teisala K, Punnonen R, et al. Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole. Genitourin Med 1986; 62:235-239.
158. Hemsell DL, Wendel GD, Gall SA, Newton ER, Gibbs RS, Knuppel RA, Lane TW, Sweet RL. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections. Am J Obstet Gynecol 1988; 158:722-727.
159. Hemsell DL, Heard MC, Hemsell PG, Nobles BJ. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease. Drugs 1988; 35(Suppl. 7):39-42.
160. Larsen JW, Voise CT, Grossman JH. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections. Clin Ther 1986; 9:77-83.
161. Obwegeser J, Kunz J, Wust J, Schar G, Steiner R, Buchi W. Clinical efficacy of amoxycillin/clavulanate in laparoscopically confirmed salpingitis. J Antimicrob Chemother 1989; 24(Suppl. B): 165-176.
162. Oriel JD. Use of quinolones in chlamydial infection. Rev Infect Dis 1989; 11:S 1273-SI276.
163. Pastorek JG, Cole C, Aldridge KE, Crapanzano JC. Aztreonam plus clindamycin as therapy for pelvic infections in women. Am J Med 1985; 78(Suppl. 2A):47-50.
164. Soper DE, Despres B. A comparison of two antibiotic regimens for treatment of pelvic inflammtory disease. Obstet Gynecol 1988; 72:7-12.
165. Sweet RL, Schachter J, Robbie MO. Failure of Beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 1983; 250:2641-2645.
166. Sweet RL, Landers DV, Schachter J, Crombleholme WR. Sulbactam/amplcillin in the treatment of acute pelvic inflammatory disease. Int J Gynecol Obstet 1989; Suppl. 2:13-9.
167. Sweet RL, Schachter J, Ohm-Smith M, et al. Treatment of acute PID: Cefoxitin plus doxycycline versus clindamycin plus tobramycin (Abstract 271). Presented at the 1985 Interscience Conference on Antimicrobial Agents and Chemotherapy.
168. Sweet RL, Schachter J, Landers DV, Ohm-Smith M, and Robbie MO. Treatment of hospitalized patients with acute pelvic inflammatory disease: Comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. Am J Obstet Gynecol 1988; 158:736-743.
169. Walters MD, Gibbs RS. A randomized comparison of gentamicln-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory diseases. Obstet Gynecol 1990; 75:867-872.
170. Wasserheit JN, Bell TA, Kiviat NB, Wolner-Hanssen P, Zabriskie V, Kirby BD, Prince EC, Holmes KK, Stamm WE, Eschenbach DA. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986; 104:187-193.
171. Wolner-Hanssen P, Paavonen J, Kiviat N, et al. Ambulatory treatment of suspected pelvic inflammatory disease with Augmentin with or without doxycycline. Am J Obstet Gynecol 1988; 158:577-579.
172. Wolner-Hanssen P, Paavonen J, Kiviat N, Young M, Eschenbach DA, Holmes KK. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Obstet Gynecol 1988; 71:595-600.
173. American Social Health Association. Genital self-examination (GSE) education initiative. National Press Conference, New York, NY July 1989.
174. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984; 251:2822-2824.
175. Becker MH, Joseph JG. AIDS and behavioral change to reduce risk: A review. Am J Public Health 1988; 78:394-410.
176. Carne CA, Weller IVD, Johnson AM, et al. Prevalence of antibodies to human immunodeficiency virus, gonorrhea rates, and changed sexual behavior in homosexual men in London. Lancet 1987; i:656-658.
177. Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease and infertility: An epidemiologic update. Epidemiol Rev 1990.
178. Centers for Disease Control. Chlamydia trachomatis infection: Policy guidelines for prevention and control. MMWR. 1985; 34:53S-74S.
179. Centers for Disease Control. Condoms for prevention of sexually transmitted disease. MMWR 1988; 37:133-137.
180. Darrow WW. Condom use and use-effectiveness in high risk populations. Sex Transm Dis 1989; 16:157-160.
181. Forrest KA, Washington AE, Daling JR, Sweet RL. Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc 1989; 81:159-165.
182. Grimes DA, Cates W. Family planning and sexually transmitted diseases. In: Holmes KK, Mardh PA, Sparling PF, et al., (eds.) Sexually Transmitted Diseases. New York, NY: McGraw-Hill Information Services Co; 1990:1087-1094.
183. Handsfield HH, Jasman LL, Roberts PL, et al. Criteria for selective screening of Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986; 255:1730-1734.
184. Howard M, McCabe JB. Helping teenagers postpone sexual involvement. Fam Plann Perspect 1990; 22:21-26.
185. Judson FN, Ehret JM, Bolin GF, Levin MJ, Rietmeijer CAM. In vitro evaluations of condoms with and without nonoxynol-9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis 1989; 16:51-56.
186. Katz BP, Danos CS, Quinn TS, Caine V, Jones RB. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis 1988; 15:11-16.
187. Kelaghan J, Rubin GL, Ory HW, et al. Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982; 248:184-187.
188. Kroger F. Compliance strategies in a clinic for treatment of sexually transmitted diseases. Sex Transm Dis 1980; 178-182.
189. Louv WC, et al. A clinical trial of nonoxynol-9 as a prophylaxis for cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections. J Infect Dis 1988; 158-518.
190. Orduna BC. Time delays critical to gonorrhea control. Des Moines: Polk County Medical Bulletin 1980; 51:79.
191. O’Reilly KKR, Aral SO. Adolescents and sexual behavior: Trends and implications for STD. J Adolesc Health Care 1985; 6:262-270.
192. Parra W, Drotman DP, Siegel K, Esteves K, Baker T. Patient counseling and behavior modification. In: Holmes K, Mardh P-A, Sparling PF, et al. (eds.) Sexually Transmitted Diseases. New York, NY: McGraw-Hill Information Services Co; 1990:1057-1068.
193. Rosenberg MJ, Jojanapithayakorn W, Feldblum PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis: A comparative clinical trial. JAMA 1987; 257:2308-2312.
194. Solomon MZ, Dejong W. Preventing AIDS and other STDs through condom promotion: A patient education intervention. Am J Public Health 1989; 79:453-458.
195. Stamm WE, Kaetz S, Holmes KK. Clinical training in venerology in the United States and Canada. JAMA 1982; 248:2020-2024.
196. Stone KR, Grimes DA, Magder LS. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986; 155:180-188.
197. Sweet RL, Blankfor-Doyle M, Robbie MO, Schachter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986; 255:2062-2064.
198. Tucker CW. Gonorrhea recidivism in Richland County, South Carolina: A report submitted to the Centers for Disease Control (CDC Contract 200-76-0672). Columbia, South Carolina Dept. of Health and Environmental Control, Venereal Disease Control Division, 1977.
199. U. S. Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Report of the U. S. Preventive Services Task Force. Baltimore MD: Williamsand Wilkins; 1989.
200. Wolner-Hanssen P, Eschenbach DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990; 263:1936-1941.